HNRNPC expression has been reported to be abnormal in a number of malignancies, including prostate cancer [10], breast cancer (BRCA) [11, 12], pancreatic ductal adenocarcinoma [13], lung adenocarcinoma (LUAD) [14], glioblastoma [15], oral squamous cell carcinoma, and hepatocellular carcinoma [16]. The gene discussed is HNRNPC; the disease is glioblastoma.